Professional Documents
Culture Documents
ANTIMICROBIALS PART 1
CDK TDK
Effect increases as concentration Effect increases as time spent above MIC
above MIC increases increases
Usually seen with – Rapidly acting Usually seen with – slowly acting drugs
drugs
Examples: Examples:
• AG • Beta lactams
• FQ • Vancomycin
• Azithromycin
Most important PK measure: Most important PK measure:
Cmax / MIC T > MIC
Usually given as – Large doses less Usually given as – Small doses more
frequently frequently or as a continuous infusion
PAE prolonged PAE negligible
Bactericidal Bacteriostatic
• Cell wall synthesis inhibitors • Protein synthesis inhibitors
▪ β-lactams except Aminoglycosides and
▪ Glycopeptides Rifampicin
• Aminoglycosides • All antimetabolites except
• Rifampicin Cotrimoxazole
• DNA gyrase inhibitors
• Cotrimoxazole
1. Ceftriaxone
2. Cefoperazone
3. Doxycycline
4. Erythromycin
5. Quinupristin / Dalfepristin
6. Rifampicin
7. Amphotericin B
8. Tigecycline
9. Tedizolid
Indications of cephalosporins:
1. Diarrhea
2. Hypersensitivity reactions
3. Nephrotoxicity
4. Bleeding
5. Hypoprothrombinemia
6. Autoimmune neutropenia and thrombocytopenia
• P. aeruginosa
• Acinetobacter
• Enterococcus
Anaerobes are inherently resistant to – Aminoglycosides (as penetration of aminoglycosides
into bacterial cells is an aerobic energy-dependent process)
Aminoglycosides:
1. GI symptoms
➢ Nausea
➢ Vomiting
➢ Abdominal pain
➢ Epigastric burning
2. Esophagitis and esophageal ulcers
3. Photosensitivity
4. Skin pigmentation
5. Nail pigmentation
6. Hepatotoxicity
7. Ototoxicity & Vestibulotoxicity (Minocycline)
8. Nephrotoxicity (except Doxycycline)
9. Fanconi’s syndrome (outdated tetracyclines)
10. Diabetes insipidus (Demeclocycline)
Contraindications to tetracyclines:
1. Pregnancy
2. Children < 8 years
Tigecycline:
ANTIMICROBIALS (ANTIMETABOLITES)
1. Crystalluria
2. Acute renal failure
3. Rashes
4. Photosensitivity
5. Hypersensitivity reactions (SJS & TEN)
6. Erythema multiforme
7. Kernicterus
Organism Resistant to
Priority 1: CRITICAL
Acinetobacter baumannii Carbapenems
Pseudomonas aeruginosa Carbapenems
Enterobacteriaceae Carbapenems, 3rd generation cephalosporins
Priority 2: HIGH
Enterococcus faecium Vancomycin
Staphylococcus aureus Methicillin, Vancomycin
Helicobacter pylori Clarithromycin
Campylobacter Fluoroquinolones
Salmonella spp Fluoroquinolones
Neisseria gonorrhoeae 3rd generation cephalosporins,
Fluoroquinolones
Priority 3: MEDIUM
Streptococcus pneumoniae Penicillins
Haemophilus influenzae Ampicillin
Shigella spp Fluoroquinolones
ANTIMICROBIALS PART 2
1. Glycopeptides
• Vancomycin
• Teicoplanin
• Telavancin
• Dalbavancin
• Oritavancin
2. Linezolid
3. Streptogramins
• Quinupristin / Dalfepiristin
4. Daptomycin
5. Mupirocin
6. 5th generation cephalosporins
• Ceftobipirole
• Ceftaroline
• Ceftolozane
7. Tigecycline
8. Cotrimoxazole
9. Ciprofloxacin
resistant
Classification of antiretrovirals:
Tenofovir:
1. Nausea
2. Vomiting
3. Diarrhea
4. Abdominal pain
5. Metallic taste
6. Lipodystrophy and lipid redistribution
7. Hypertriglyceridemia
8. Hypercholesterolemia
9. Increased risk of atherosclerosis
10. Renal stones – Indinavir
U.S. Department of Health and Human Services Guidelines (2010): Start ART in –
1. All symptomatic HIV patients
2. Asymptomatic patients with CD4 ≤ 350 / µL
3. HIV + HBV / HCV patients
4. Pregnant HIV +ve women
5. Patients with HIV nephropathy
Post-exposure prophylaxis:
Dose of Oseltamivir:
1. Nephrotoxicity (dose-limiting)
2. Interstitial nephritis
3. Symptomatic hypocalcaemia (dose-limiting)
4. Hypokalemia
5. Hypomagnesemia
6. Neurotoxicity
7. Painful genital ulcerations (rare)
ANTIFUNGALS (CLASSIFICATION)
• Amphotericin B
• Echinocandins
• Azoles – Posaconazole and Isavuconazole
ANTIMICROBIALS PART 3
GROUP EXAMPLES
Group I • Isoniazid (H)
Oral first line agents • Rifampicin (R)
• Pyrazinamide (Z)
• Ethambutol (E)
• Rifabutin
• Rifapentine
Group II • Streptomycin
Injectables • Amikacin
• Capreomycin
• Kanamycin
Group III • Ciprofloxain
Fluoroquinolones • Ofloxacin
• Levofloxacin
• Moxifloxacin
Bedaquiline:
Drug-resistant TB:
Treatment of MDR-TB:
Regimen 1:
Minimum of 5 drugs –
• Pyrazinamide
• One drug from Group A (Fluoroquinolone)
• One drug from Group B (injectable)
• Other drugs from Group C
If the minimum number cannot be met from the above, one drug from D2 and one or more
from D3 can be selected
ANTIMALARIALS
Treatment of malaria:
Situation in India:
• P. vivax – CQ-sensitive
• P. falciparum – CQ-resistant
Chemoprophylaxis of malaria:
Immediate –
1. Nausea
2. Vomiting
3. Anorexia
4. Epigastric pain
Long-term:
1. Retinopathy (Irreversible)
2. Corneal deposits (Reversible)
3. Ototoxicity – Loss of hearing
4. Greying of hair
5. Rashes
6. Photoallergy
7. Mental disturbances
8. Myopathy
1. Amphotericin B
2. Sodium stibogluconate
3. Pentamidine
4. Miltefosine
5. Ketoconazole
6. Paromomycin
7. Allopurinol
Indications of albendazole:
1. Ascariasis
2. Hookworm infestation
3. Enterobiasis
4. Trichuriasis
5. Trichinosis
6. Strongyloidiasis
7. Neurocysticercosis
8. Cutaneous larva migrans
9. Visceral larva migrans
10. Hydatid disease
11. Other echinococcal infections
12. Lymphatic filariasis
Indications of triclabendazole:
1. Ascariasis
2. Fasciola hepatica
3. Fasciola gigantica
4. Paragonimiasis
5. Ectoparasitic infections
Treatment of strongyloidiasis:
❑ ❑ ❑